182 related articles for article (PubMed ID: 37594079)
21. Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss.
Zhang P; Ye J; Dai J; Wang Y; Chen G; Hu J; Hu Q; Fei J
Front Endocrinol (Lausanne); 2022; 13():963237. PubMed ID: 36601012
[TBL] [Abstract][Full Text] [Related]
22. Flavonoids compounds from Tridax procumbens inhibit osteoclast differentiation by down-regulating c-Fos activation.
Al Mamun MA; Asim MMH; Sahin MAZ; Al-Bari MAA
J Cell Mol Med; 2020 Feb; 24(4):2542-2551. PubMed ID: 31919976
[TBL] [Abstract][Full Text] [Related]
23. Effect of
Heo J; Kim M; Kim JH; Shin H; Lim SE; Jung HS; Sohn Y; Ku J
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297038
[TBL] [Abstract][Full Text] [Related]
24. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.
Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J
Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247
[No Abstract] [Full Text] [Related]
25. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
26. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
[TBL] [Abstract][Full Text] [Related]
27. Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss.
Hou W; Chen M; Ye C; Chen E; Li W; Zhang W
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358952
[TBL] [Abstract][Full Text] [Related]
28. PDK2 Deficiency Prevents Ovariectomy-Induced Bone Loss in Mice by Regulating the RANKL-NFATc1 Pathway During Osteoclastogenesis.
Lee JM; Kim MJ; Lee SJ; Kim BG; Choi JY; Lee SM; Ham HJ; Koh JM; Jeon JH; Lee IK
J Bone Miner Res; 2021 Mar; 36(3):553-566. PubMed ID: 33125772
[TBL] [Abstract][Full Text] [Related]
29. Leonurus sibiricus L. ethanol extract promotes osteoblast differentiation and inhibits osteoclast formation.
Kim JH; Kim M; Jung HS; Sohn Y
Int J Mol Med; 2019 Sep; 44(3):913-926. PubMed ID: 31524244
[TBL] [Abstract][Full Text] [Related]
30. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
[TBL] [Abstract][Full Text] [Related]
31. Abeliophyllum distichum Nakai alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro.
Kim EY; Kim JH; Kim M; Park JH; Sohn Y; Jung HS
J Ethnopharmacol; 2020 Jul; 257():112828. PubMed ID: 32268206
[TBL] [Abstract][Full Text] [Related]
32. Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.
Li X; Wang Y; Li L; Zhou S; Zhao F
Cell Biol Toxicol; 2021 Dec; 37(6):849-871. PubMed ID: 33423118
[TBL] [Abstract][Full Text] [Related]
33. Ellagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption.
Lin X; Yuan G; Li Z; Zhou M; Hu X; Song F; Shao S; Fu F; Zhao J; Xu J; Liu Q; Feng H
J Cell Physiol; 2020 Sep; 235(9):5951-5961. PubMed ID: 32026468
[TBL] [Abstract][Full Text] [Related]
34. Glycyrrhizae Radix Inhibits Osteoclast Differentiation by Inhibiting c-Fos-Dependent NFATc1 Expression.
Rho TW; Lee SY; Han SY; Kim JH; Lee KH; Kim DS; Kwak HB; Kim YK
Am J Chin Med; 2017; 45(2):283-298. PubMed ID: 28231743
[TBL] [Abstract][Full Text] [Related]
35. Asiatic Acid Attenuates Osteoporotic Bone Loss in Ovariectomized Mice Through Inhibiting NF-kappaB/MAPK/ Protein Kinase B Signaling Pathway.
Dong M; Zeng J; Yang C; Qiu Y; Wang X
Front Pharmacol; 2022; 13():829741. PubMed ID: 35211021
[TBL] [Abstract][Full Text] [Related]
36. Zanthoxylum piperitum alleviates the bone loss in osteoporosis via inhibition of RANKL-induced c-fos/NFATc1/NF-κB pathway.
Kim MH; Lee H; Ha IJ; Yang WM
Phytomedicine; 2021 Jan; 80():153397. PubMed ID: 33130475
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss.
Lin NY; Chen CW; Kagwiria R; Liang R; Beyer C; Distler A; Luther J; Engelke K; Schett G; Distler JH
Ann Rheum Dis; 2016 Jun; 75(6):1203-10. PubMed ID: 26113650
[TBL] [Abstract][Full Text] [Related]
38. Oxidation derivative of (-)-epigallocatechin-3-gallate (EGCG) inhibits RANKL-induced osteoclastogenesis by suppressing RANK signaling pathways in RAW 264.7 cells.
Xu H; Liu T; Li J; Xu J; Chen F; Hu L; Zhang B; Zi C; Wang X; Sheng J
Biomed Pharmacother; 2019 Oct; 118():109237. PubMed ID: 31376653
[TBL] [Abstract][Full Text] [Related]
39. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.
Qiu Z; Li L; Huang Y; Shi K; Zhang L; Huang C; Liang J; Zeng Q; Wang J; He X; Qin L; Wang X
J Orthop Translat; 2022 Mar; 33():55-69. PubMed ID: 35228997
[TBL] [Abstract][Full Text] [Related]
40. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]